Changeflow GovPing Healthcare & Life Sciences Polyamine Reporters - Pushkal Sharma, Ankur Jain
Routine Rule Added Final

Polyamine Reporters - Pushkal Sharma, Ankur Jain

Favicon for changeflow.com USPTO Patent Applications - Peptides (C07K)
Published
Detected
Email

Summary

The USPTO published patent application US20260109740A1 by inventors Pushkal Sharma and Ankur Jain on April 23, 2026. The application discloses polynucleotides comprising a polyamine-responsive element and a reporter protein coding sequence, where interaction between a polyamine and the polyamine-responsive element modulates expression of the reporter protein. The invention enables methods of reporting and detecting intracellular polyamines and polyamine analogs.

“interaction between a polyamine and the polyamine-responsive element modulates expression of the reporter protein”

USPTO , verbatim from source
Published by USPTO on changeflow.com . Detected, standardized, and enriched by GovPing. Review our methodology and editorial standards .

About this source

USPTO classification C07K covers peptides: short amino-acid chains that form the backbone of antibodies, hormones, vaccines, and increasingly a wider class of therapeutic modalities. Every newly published application in C07K lands in this feed, around 175 a month. Applications publish 18 months after filing, so this feed reveals what antibody engineering groups, vaccine developers, and plant biotech researchers were working on in the prior year and a half. Watch this if you compete in biologics, file freedom-to-operate analyses on antibody drug candidates, scout acquisition targets in vaccine platforms, or track protein-based agricultural biotech filings.

What changed

The USPTO published Application US20260109740A1, a patent application disclosing polynucleotides comprising a polyamine-responsive element and a reporter protein coding sequence for detecting intracellular polyamines and polyamine analogs.

Affected parties include biotechnology and pharmaceutical companies engaged in polyamine-targeted therapeutic development or diagnostic assay design. Patent professionals should monitor this application's prosecution for freedom-to-operate considerations.

Archived snapshot

Apr 23, 2026

GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.

← USPTO Patent Applications

Polyamine Reporters

Application US20260109740A1 Kind: A1 Apr 23, 2026

Inventors

Pushkal Sharma, Ankur Jain

Abstract

The disclosure provides, in various embodiments, polynucleotides comprising a polyamine-responsive element and a reporter protein coding sequence encoding a reporter protein, wherein interaction between a polyamine and the polyamine-responsive element modulates expression of the reporter protein. The disclosure also provides, in various embodiments, vectors cells, and kits comprising the polynucleotides, methods of reporting an intracellular polyamine, and methods of detecting and/or reporting an intracellular polyamine analog.

CPC Classifications

C07K 14/47 C12N 15/625 C12N 15/63 G01N 33/68 C07K 2319/09 C07K 2319/60 C07K 2319/95

Filing Date

2025-08-22

Application No.

19307589

View original document →

Get daily alerts for USPTO Patent Applications - Peptides (C07K)

Daily digest delivered to your inbox.

Free. Unsubscribe anytime.

About this page

What is GovPing?

Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission

What's from the agency?

Source document text, dates, docket IDs, and authority are extracted directly from USPTO.

What's AI-generated?

The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.

Last updated

Classification

Agency
USPTO
Published
April 23rd, 2026
Instrument
Rule
Branch
Executive
Legal weight
Binding
Stage
Final
Change scope
Minor

Who this affects

Applies to
Biotechnology companies Pharmaceutical companies
Industry sector
3254.1 Biotechnology
Activity scope
Patent application IP filing
Geographic scope
United States US

Taxonomy

Primary area
Intellectual Property
Operational domain
Quality Assurance
Topics
Biotechnology Pharmaceuticals

Get alerts for this source

We'll email you when USPTO Patent Applications - Peptides (C07K) publishes new changes.

Free. Unsubscribe anytime.

You're subscribed!